ABVX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

7.16

Margin Of Safety %

Put/Call OI Ratio

0.49

EPS Next Q Diff

EPS Last/This Y

1.8

EPS This/Next Y

0.39

Price

97.4

Target Price

143.51

Analyst Recom

1.39

Performance Q

-10.94

Upside

-170.0%

Beta

1.38

Ticker: ABVX

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-06-02	ABVX	72.77	0.56	0.69	89345
2026-06-03	ABVX	90.15	0.46	0.34	110798
2026-06-04	ABVX	103.86	0.42	0.48	136742
2026-06-05	ABVX	101.63	0.43	0.45	144677
2026-06-08	ABVX	101.35	0.44	1.54	129468
2026-06-09	ABVX	102.67	0.53	0.55	139299
2026-06-10	ABVX	98.09	0.54	0.43	141976
2026-06-11	ABVX	100.79	0.54	0.41	145553
2026-06-12	ABVX	96.58	0.53	0.35	149511
2026-06-15	ABVX	98.4	0.50	0.47	147150
2026-06-16	ABVX	97.48	0.51	0.54	161021
2026-06-17	ABVX	100.1	0.51	0.62	167800
2026-06-18	ABVX	99.01	0.53	1.03	186243
2026-06-22	ABVX	101.74	0.51	0.30	161486
2026-06-23	ABVX	98.49	0.49	0.52	176278
2026-06-24	ABVX	92.52	0.48	0.50	181936
2026-06-25	ABVX	92.33	0.49	0.75	197345
2026-06-26	ABVX	97.46	0.49	0.59	206213
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-06-01	ABVX	129.54	24.5	-	-3.45
2026-06-02	ABVX	72.56	24.5	-	-3.45
2026-06-03	ABVX	90.14	30.6	-	-3.34
2026-06-04	ABVX	105.04	30.6	-	-3.34
2026-06-05	ABVX	101.55	30.6	-	-3.54
2026-06-08	ABVX	101.46	26.6	-	-3.54
2026-06-09	ABVX	102.65	26.6	-	-3.60
2026-06-10	ABVX	98.06	26.6	-	-3.60
2026-06-11	ABVX	100.79	26.6	-	-3.60
2026-06-12	ABVX	96.56	26.6	-	-3.60
2026-06-15	ABVX	98.34	26.6	-	-3.60
2026-06-16	ABVX	97.50	26.6	-	-3.60
2026-06-17	ABVX	100.09	26.6	-	-3.60
2026-06-18	ABVX	99.03	26.6	-	-3.60
2026-06-22	ABVX	101.70	26.7	-	-3.60
2026-06-23	ABVX	98.48	26.7	-	-3.60
2026-06-24	ABVX	92.60	26.7	-	-3.60
2026-06-25	ABVX	92.36	26.7	-	-3.60
2026-06-26	ABVX	97.40	-1.8	-	-3.69
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-06-02	ABVX	0.00	-6.81	3.64
2026-06-03	ABVX	0.00	-6.81	3.64
2026-06-04	ABVX	0.00	-6.81	3.64
2026-06-05	ABVX	0.00	-6.81	3.64
2026-06-08	ABVX	0.00	-7.24	3.64
2026-06-09	ABVX	0.00	-7.24	3.64
2026-06-10	ABVX	0.00	-7.24	4.48
2026-06-11	ABVX	0.00	-7.24	4.48
2026-06-12	ABVX	0.00	-7.24	4.48
2026-06-15	ABVX	0.00	-1.50	4.47
2026-06-16	ABVX	0.00	-1.50	4.47
2026-06-17	ABVX	0.00	-1.50	4.47
2026-06-18	ABVX	0.00	-1.50	4.47
2026-06-22	ABVX	0.00	-1.63	4.47
2026-06-23	ABVX	0.00	-1.63	4.47
2026-06-24	ABVX	0.00	-1.63	4.47
2026-06-25	ABVX	0.00	-1.63	4.47
2026-06-26	ABVX	0.00	-1.63	7.16
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

-0.71

Avg. EPS Est. Current Quarter

-0.91

Avg. EPS Est. Next Quarter

-0.71

Insider Transactions

Institutional Transactions

-1.63

Beta

1.38

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

34.6

Max Drawdown 5-Year %

Target Price

143.51

P/E

Forward P/E

PEG

P/S

P/B

15.62

P/Free Cash Flow

EPS

-5.25

Average EPS Est. Cur. Y

-3.69

EPS Next Y. (Est.)

-3.3

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.95

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-88.2

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

0.51

EBIT Estimation

◆ ABVX Healthcare

$97.50

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

13/25

Volume

7/15

Valuation

10/20

TP/AR

2/10

Options

5/10

RSI

44.6

Range 1M

43.6%

Sup Dist

9.2%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

16/30

Estimates

0/20

Inst/Vol

2/15

Options

5/10

EPS Yr

47.2%

EPS NY

-20.9%

52W%

64.3%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +47.2% upside

Quality

2/30

Valuation

10/30

Growth

12/25

Stability

6/10

LT Trend

0/5

Upside

+47.2%

Quality

ABVX — P/E HistoricalBiotechnology

Abivax SA

Sector: Healthcare

Industry: Biotechnology

Employees: 80

ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.

ABVX

Latest News

—

Caricamento notizie per ABVX…

stock quote shares ABVX – Abivax ADR Stock Price stock today

news today ABVX – Abivax ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch ABVX – Abivax ADR yahoo finance google finance

stock history ABVX – Abivax ADR invest stock market

stock prices ABVX premarket after hours

ticker ABVX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ABVX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y